Publications
- 12.09.22 Design, synthesis, and characterization of linkers that utilize a two-stage release mechanism to improve the delivery of the sulfonamide TLR4 signaling inhibitor TAK-242 (Resatorvid)
- 12.07.22 “Design of New Prodrugs for Organ Transplants” – Baylor Present Your Ph.D., – December 2022
- 10.22.22 “Synthesis and Characterization of Improved β-eliminative Linkers for the Bioconjugation and Sustained Release of the Tlr4 Inhibitor Tak-242 (Resatorvid) for Applications in Transplantation” – ACS Southeastern Regional Meeting, – October 2022
- 08.22.22 “Synthesis and Characterization of Improved β-eliminative Linkers for the Bioconjugation and Sustained Release of Tak-242 (Resatorvid)” – American Chemical Society Fall 2022 Conference, – August 2022
- 04.15.22 “Novel β-eliminative Linkers for the Delivery of Tak-242 to Transplanted Tissue” – Baylor University, – April 2022
- 11.15.21 Gemfibrozil derivatives as activators of soluble guanylyl cyclase – A structure-activity study
- 10.31.21 “Design, Synthesis, and Half-life Determination of Improved B-eliminative Linkers for the Conjugation of TAK-242 to Transplanted Tissue” ACS Southwest Regional Meeting – October 2021
- 10.14.21 “Bio-Conjugation and Flow Cytometry” Baylor University Advanced Instrumentation Workshop – October 2021
- 12.28.18 Chemical Strategies for Improving Islet Transplant Outcomes
- 07.31.17 HBr–DMPU: The First Aprotic Organic Solution of Hydrogen Bromide
Back to Full List